Latest Investment News

RooLife Group (ASX: RLG) reported a striking 144% increase in sales revenue for Q2 FY2025, driven by the launch of new online stores across China, Hong Kong, Australia, and India. The company is investing heavily in product development and marketing to capitalize on booming health and wellness markets.

Prescient Therapeutics has secured FDA clearance for its PTX-100 Phase 2 trial targeting relapsed/refractory cutaneous T-cell lymphoma, while also appointing James McDonnell as its new CEO. The company reports steady progress in its cell therapy platforms and maintains a solid cash position bolstered by a recent R&D tax rebate.

Ausmon Resources Limited reports steady progress in rare earth and base metals exploration across Australia, with key drilling programs planned for 2025 despite a tight cash position.

Epsilon Healthcare Limited reported a modest cash increase in its December quarter but remains under administration with no unused financing facilities, raising questions about its operational future.

Tombador Iron Limited reported a modest net cash outflow of $317,000 for the December 2024 quarter, yet holds robust cash reserves of $10.825 million, underpinning over 34 quarters of operational funding.

Greenwing Resources reports significant progress in its lithium and graphite projects, notably expanding the lithium brine footprint at its San Jorge Project in Argentina and advancing exploration in Madagascar amid regulatory shifts.

Tombador Iron Limited reports a modest cash increase and ongoing progress toward acquiring the Colomi Iron Project in Brazil, while managing royalty income from its sold Tombador project.

Alligator Energy reports significant progress across its uranium portfolio, including regulatory milestones at Samphire and promising drilling results at Big Lake and Nabarlek North, supported by a solid cash position of $20.2 million.

Golden Cross Resources continues to push forward with joint venture discussions to finance its flagship Copper Hill project, while planning extensive geophysical surveys and addressing regulatory challenges.

Jayride Group reports a sharp decline in bookings amid supplier payment challenges but eyes growth through API technology and cost cuts.

CZR Resources faces ongoing delays in FIRB approval for its $102 million Robe Mesa sale, prompting a strategic pause in exploration and an extension of its loan facility to sustain operations.

Ragnar Metals advances its Swedish exploration with a significant spodumene pegmatite discovery at Orrvik and promising uranium assays at multiple new projects, while strengthening its strategic position through a key investment in Kaiser Reef.